A small-cap company in the life sciences sector has announced its unaudited results for the quarter (Q2) and half-year (H1) ended September 30, 2025. The company has also declared a 900 per cent dividend for the shareholders. The company has also announced the record and payment date for the dividend entitlement and payout.

See Full Page